Background Almost 30 years after the first human implants, ICD therapy has become the
treatment of choice in patients at risk of developing malignant ventricular arrhythmias. 1, 2 …

Background—Methods to identify high-risk patients and timing of implantable cardioverter-
defibrillator (ICD) therapy after ST-elevation myocardial infarction need further optimization …

Background: Studies have examined the relationship between shocks and anxiety, but little
is known about the role of personality. Our aim was to examine the determinants of self …

Background: Device acceptance may comprise one of the keys to identifying implantable
cardioverter defibrillator (ICD) patients at risk for adverse health outcomes in clinical …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has
demonstrated safety and efficacy for the treatment of malignant ventricular arrhythmias …

Background: This study examined the impact of clustering of device‐related concerns and
Type D personality on anxiety and depressive symptoms during a six‐month period and the …

With optimized programming, the rate of inappropriate ventricular tachyarrhythmia detection
is significantly reduced. Particularly the prevention of inappropriate shocks has important …

With improvement in medical, interventional, and surgical therapies for congenital heart
disease (CHD), most patients with CHD are surviving into adulthood such that there are now …

High-voltage electrical defibrillation remains the only reliable method of quickly controlling
life-threatening cardiac arrhythmias. This paper is devoted to studying an alternative …

Background—Implantable cardioverter-defibrillator (ICD) shock is a critical event to patients
associated with well-being after implantation, although other factors may play an equally …